Human coronavirus HKU1

IDbyDNA Boosts Its Global Metagenomic Respiratory Pathogen/AMR Surveillance Solution to Now Offer Enhanced SARS-CoV-2 Variant Interpretation

Retrieved on: 
Tuesday, March 23, 2021
Sarbecovirus, Zoonoses, Branches of biology, Animal diseases, Articles, Severe acute respiratory syndrome coronavirus, Polymerase chain reaction, COVID-19, Severe acute respiratory syndrome, Human coronavirus HKU1

The widely used PCR and rapid antigen tests cannot detect these variants, allowing the virus to evolve in stealth mode.

Key Points: 
  • The widely used PCR and rapid antigen tests cannot detect these variants, allowing the virus to evolve in stealth mode.
  • Early identification and monitoring of SARS-CoV-2 will help public health officials and researchers better understand the evolving virus.
  • Today, IDbyDNA is announcing significant enhancements to its fully automated data analysis suite for the combined IDbyDNA and Illumina, Inc. Respiratory Pathogen ID/AMR Target Enrichment Panel (RPIP).
  • "The key to managing COVID-19, influenza, and other emerging respiratory infections, is more robust and real-time genomic-level insights into circulating strains.

"Corona Virus Vaccine Market Size is Projected to reach 75.75 Billion by end of 2021, Says Brandessence Market Research"

Retrieved on: 
Tuesday, March 2, 2021
Coronaviridae, Medical specialties, Nidovirales, Zoonoses, Sarbecovirus, Bat virome, Vaccination, Virology, Human coronavirus 229E, Human coronavirus OC43, Coronavirus, Human coronavirus HKU1

The global corona virus vaccine market is expected to grow at significant growth rate due to number of driving factors.

Key Points: 
  • The global corona virus vaccine market is expected to grow at significant growth rate due to number of driving factors.
  • The study provides a crucial view of global corona virus vaccine market by segmenting the market based on infection type, vaccine type and region & country level.
  • Based on infection, the corona virus vaccine market is segmented into HCoV-229E, HCoV-OC43, HKU1-CoV, NL63, MERS-CoV, New Haven CoV, SARS-CoV and SARS-CoV-2.
  • Based on vaccine type, the market is segmented into S-protein based coronavirus vaccine, live attenuated coronavirus vaccine, inactivated coronavirus vaccine, MRNA vaccine and DNA-based vaccine.

"Corona Virus Vaccine Market Size is Projected to reach 75.75 Billion by end of 2021, Says Brandessence Market Research"

Retrieved on: 
Tuesday, March 2, 2021
Coronaviridae, Medical specialties, Nidovirales, Zoonoses, Sarbecovirus, Bat virome, Vaccination, Virology, Human coronavirus 229E, Human coronavirus OC43, Coronavirus, Human coronavirus HKU1

The global corona virus vaccine market is expected to grow at significant growth rate due to number of driving factors.

Key Points: 
  • The global corona virus vaccine market is expected to grow at significant growth rate due to number of driving factors.
  • The study provides a crucial view of global corona virus vaccine market by segmenting the market based on infection type, vaccine type and region & country level.
  • Based on infection, the corona virus vaccine market is segmented into HCoV-229E, HCoV-OC43, HKU1-CoV, NL63, MERS-CoV, New Haven CoV, SARS-CoV and SARS-CoV-2.
  • Based on vaccine type, the market is segmented into S-protein based coronavirus vaccine, live attenuated coronavirus vaccine, inactivated coronavirus vaccine, MRNA vaccine and DNA-based vaccine.

FDA Issues Emergency Use Authorization for ChromaCode's High-Throughput HDPCR™ SARS-CoV-2 Real-Time PCR Assay

Retrieved on: 
Wednesday, June 10, 2020
Viruses, Coronaviridae, Zoonoses, Animal virology, Emergency Use Authorization, Food and Drug Administration, Severe acute respiratory syndrome-related coronavirus, Coronavirus, Severe acute respiratory syndrome, Digital polymerase chain reaction, Human coronavirus HKU1, SARS coronavirus main proteinase

CARLSBAD, Calif., June 10, 2020 /PRNewswire/ -- ChromaCode, Inc., a company redefining molecular testing through data science, today announced that the U.S. Food and Drug Administration has granted Emergency Use Authorization of ChromaCode's HDPCR SARS-CoV-2 Real-Time PCR Assay.

Key Points: 
  • CARLSBAD, Calif., June 10, 2020 /PRNewswire/ -- ChromaCode, Inc., a company redefining molecular testing through data science, today announced that the U.S. Food and Drug Administration has granted Emergency Use Authorization of ChromaCode's HDPCR SARS-CoV-2 Real-Time PCR Assay.
  • The assay was launched in April after validation by ChromaCode, in line with the FDA's EUA regulations.
  • To address this, ChromaCode guarantees ongoing supply for customers who sign an agreement with us."
  • The HDPCR SARS-CoV-2 Real-Time PCR Assay is intended to detect severe acute respiratory syndrome coronavirus 2 from nasopharyngeal swab specimens from patients suspected by their healthcare provider of having contracted COVID-19.

ChromaCode Launches High-Throughput HDPCR™ SARS-CoV-2 Assay

Retrieved on: 
Tuesday, April 21, 2020
Viruses, Zoonoses, Coronaviridae, Animal virology, Severe acute respiratory syndrome-related coronavirus, Coronavirus, Severe acute respiratory syndrome, CoV, Assay, Human coronavirus HKU1, SARS coronavirus main proteinase

CARLSBAD, Calif., April 21, 2020 /PRNewswire/ --ChromaCode, Inc., a company redefining molecular testing through data science, today announced the launch of the HDPCR SARS-CoV-2 real-time PCR Assay.

Key Points: 
  • CARLSBAD, Calif., April 21, 2020 /PRNewswire/ --ChromaCode, Inc., a company redefining molecular testing through data science, today announced the launch of the HDPCR SARS-CoV-2 real-time PCR Assay.
  • The assay has been validated by ChromaCode, and an independent review of the validation data by the U.S. Food and Drug Administration is pending.
  • The HDPCR SARS-CoV-2 assay is intended to detect severe acute respiratory syndrome coronavirus 2 from nasopharyngeal swab specimens from patients suspected by their healthcare provider of having contracted COVID-19.
  • HDPCR SARS-CoV-2 results are analyzed in ChromaCode's HIPAA-compliant cloud-based software, ChromaCode Cloud, which provides laboratories with an end-to-end solution to streamline test workflow and results interpretation.